Literature DB >> 27471232

Two strikes against CLL.

Rosa Lapalombella1.   

Abstract

Year:  2016        PMID： 27471232     DOI： 10.1182/blood-2016-06-719864

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy.

Authors:  Pamela Munster; Monica Mita; Amit Mahipal; John Nemunaitis; Christophe Massard; Tom Mikkelsen; Cristina Cruz; Luis Paz-Ares; Manuel Hidalgo; Dana Rathkopf; George Blumenschein; David C Smith; Barbara Eichhorst; Tim Cloughesy; Ellen H Filvaroff; Shaoyi Li; Heather Raymon; Hans de Haan; Kristen Hege; Johanna C Bendell
Journal:  Cancer Manag Res       Date:  2019-12-13       Impact factor: 3.989

2.  Dual mTOR/DNA-PK Inhibitor CC-115 Induces Cell Death in Melanoma Cells and Has Radiosensitizing Potential.

Authors:  Felix Bürkel; Tina Jost; Markus Hecht; Lucie Heinzerling; Rainer Fietkau; Luitpold Distel
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.